Huang HB, et al. - This study appraised high-flow nasal cannula oxygen therapy (HFNC) as a management option in immunocompromised patients with acute respiratory failure, compared with other oxygen technique. Data reported a significant benefit of HFNC in this patient population in terms of improved outcomes.